Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators
Background: Cancer patients are alleged to have poor coronavirus disease 2019 (COVID-19) outcomes. However, no systematic or comprehensive analyses of the role and mechanisms of COVID-19 receptor-related regulators in cancer are available.Methods: We comprehensively evaluated the genomic alterations...
Main Authors: | Jian Zhang, Huali Jiang, Kunpeng Du, Tao Xie, Baiyao Wang, Chengcong Chen, Bohong Cen, Yawei Yuan, Jiacai Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.662460/full |
Similar Items
-
Integrative Pan-Cancer Analysis Reveals Decreased Melatonergic Gene Expression in Carcinogenesis and RORA as a Prognostic Marker for Hepatocellular Carcinoma
by: Yi Zou, et al.
Published: (2021-03-01) -
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role
by: Hua Zhu, et al.
Published: (2021-09-01) -
Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data
by: Ning Zhao, et al.
Published: (2020-04-01) -
Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
by: Bolun Zhou, et al.
Published: (2021-04-01) -
Development of cancer prognostic signature based on pan-cancer proteomics
by: Weiguo Huang, et al.
Published: (2020-01-01)